News Release

Penn Medicine awarded $9.5 million grant from The Warren Alpert Foundation to increase diversity in genetic counseling programs

The Warren Alpert Foundation funding becomes the most significant award to support genetic counseling education nationwide

Grant and Award Announcement

University of Pennsylvania School of Medicine

Students in classroom

image: Grant to support education to increase diversity in genetic counseling view more 

Credit: Getty images

PHILADELPHIA —  Penn Medicine has been awarded a $9.5 million grant from The Warren Alpert Foundation (WAF) to continue its efforts to increase diversity in genetic counseling, a field that, despite impressive leaps forward in genetic knowledge, lacks a diverse workforce. The Alliance to Increase Diversity in Genetic Counseling grant will support 40 underrepresented students in five genetic counseling programs in the Northeastern U.S. over five years to expand all dimensions of diversity. The Perelman School of Medicine at the University of Pennsylvania’s Master of Science in Genetic Counseling Program will lead this effort, joined by participating Genetic Counseling master’s programs at Boston University School of Medicine, Rutgers, The State University of New Jersey, Sarah Lawrence College, and the University of Maryland School of Medicine. Ten students will be selected yearly to receive full tuition support and a cost of living stipend.

The University of Pennsylvania's Master of Science in Genetic Counseling Program (MSGC) and the collaborative programs are committed to increasing diversity and inclusion in the genetic counseling field and encouraging post-graduate training and career advancement opportunities for genetic counselors. Previous philanthropic gifts to the MSGC program have supported a robust summer internship for undergraduates who are underrepresented in Genetic Counseling, which, in its first year, led to two rising juniors and seniors to learn about the field and consider applying to the program. The Class of 2023 is the Penn MSGC’s most diverse ever, with 35% of students from underrepresented backgrounds.

"We are honored to receive this grant from The Warren Alpert Foundation to continue to expand diversity and inclusion in genetic counseling while growing the overall genetic counseling workforce," said Daniel J. Rader, MD, Chair of the Department of Genetics in the Perelman School of Medicine and Chief of the Divisions of Human Genetics at both Penn and Children’s Hospital of Philadelphia. “The Foundation is extraordinarily forward-thinking in making this generous funding available to address a critical need as the implementation of genomic medicine continues to rapidly expand.”

"On the 50th anniversary of genetic counseling being established as a field, we celebrate the first time an alliance of genetic counseling programs has collaborated to increase diversity and inclusion with scholarships, post-graduate training, and career advancements for genetic counselors," said Kathleen Valverde, PhD, LCGC, Program Director of the Penn MSGC.

A key rationale for increasing diversity in the genetic counseling workforce is to improve support for patients from underrepresented backgrounds. The field is currently comprised of 95 percent white females. Therefore, underrepresentation of genetic counselors from diverse backgrounds can strain critical dialogue between genetic counselors and patients, whose health outcomes are often improved through interaction with medical professionals they can relate to more personally. Unless genetic counseling becomes more accessible, existing disparities will be exacerbated. Addressing this issue will require integrated strategies, including expanding genetic research, improving genetic literacy, and enhancing access to genetic technologies and genetic counseling among underrepresented populations in a way that avoids stigmatization and other harms.

"Supporting innovative organizations dedicated to understanding and curing disease through groundbreaking research, scholarship, and service is why we are delighted to award Penn with this generous grant from The Warren Alpert Foundation," said August Schiesser, Executive Director of The Warren Alpert Foundation. "Recruiting and training underrepresented individuals in genetic counseling will increase the numbers of professionals in the field, leading to an increase in access to community-based genetic education and genetic counseling services delivered by individuals who reflect different populations."

"The Penn MSGC program leadership brings extensive experience in genetic counseling education and, with this grant, it will expand its reach to diverse students preparing them to be successful professionals who will advance the field of genetic counseling," said Emma Meagher, MD, a professor of Medicine and Pharmacology, Chief Clinical Research Officer and Associate Dean of Master and Certificate Programs in the Perelman School of Medicine at Penn.

Interested applicants for Penn can visit for more information. Application deadlines are as follows: Penn Medicine (Jan. 5, 2022), Boston University School of Medicine (Dec. 15, 2021), Rutgers University (Dec. 18, 2011) Sarah Lawrence College (Dec. 17, 2021), and the University of Maryland School of Medicine (Jan. 10, 2022). Ten students will be selected yearly to receive full tuition support and a cost of living stipend.

The Warren Alpert Foundation AID-GC Program leadership includes Kathleen Berentsen Swenson, MS, MPH, CGC, Director of the Boston University School of Medicine Master’s Program in Genetic Counseling; Claire Davis, EdD, CGC, Program Director, and Janelle Villiers, MS, CGC, Assistant Director of the Joan H. Marks Graduate Program in Human Genetics at Sarah Lawrence College; Jessica Rispoli Joines, MS, LCGC, Director of the Genetic Counseling Master’s Program at Rutgers University; and Shannan Dixon, MS, CGC, Director of the Master’s in Genetic Counseling Training Program at the University of Maryland School of Medicine.


Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $8.9 billion enterprise.

The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $496 million awarded in the 2020 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center—which are recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report—Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; and Pennsylvania Hospital, the nation's first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.

Penn Medicine is powered by a talented and dedicated workforce of more than 44,000 people. The organization also has alliances with top community health systems across both Southeastern Pennsylvania and Southern New Jersey, creating more options for patients no matter where they live.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2020, Penn Medicine provided more than $563 million to benefit our community.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.